Viking Therapeutics Rises 2.88% as Shares Remain Down for Month
The shares gained in the latest session, while Zacks consensus estimates point to a projected quarterly loss and no annual revenue.
Makkler Newsroom · Oct 10, 01:20 AM · 1 min read
Viking Therapeutics, Inc. VKTX
NASDAQHealth TechnologyUnited States
$29.22+1.64 (+5.95%)
Market closed· · USD · Data may be delayed
- Day's range
- 26.6929.96
- 52-week range
- 23.8243.10
Financial health
– / 5
Analyst view · 21 firms
Buy19 buy · 2 hold · 0 sell
Avg. target $95.32 (+226.2%)
Prices may be delayed and are for informational purposes only - not investment advice.